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Is there no future for renal
BOLD-MRI?
To the Editor: We read with interest the recent article by
Michaely et al.1 in which it was stated that renal blood oxygen
level-dependent magnetic resonance imaging (BOLD-MRI) does
not reﬂect renal function in chronic kidney disease (CKD), a
conclusion that is in direct contrast to our recent results.2 We
strongly support the statement3 from the same issue that renal
tissue oxygenation appears to be dependent on CKD severity as
well as on the etiology of the underlying kidney disease. The
causes of chronic renal hypoxia are remarkably multifactorial,4
and while we have veriﬁed a relationship between BOLD-MRI
T2* values and estimated glomerular ﬁltration rates in non-
diabetic nephropathy, no association has been shown in cases of
diabetic nephropathy.2 Thus, etiological diversity in CKD might
have a far greater, and more pernicious, inﬂuence on BOLD-MRI
results than thought by Michaely et al. As the kidney is
surrounded by adipose tissue, removal of the out-of-phase
subtraction effect caused by this tissue is vital to minimizing
ﬂuctuations in T2* values. We, therefore, used in-phase echo time
(TE) of the longest possible duration to limit the T2* errors and
provide more accurate data, while balancing the signal-to-noise
ratio. Michaely et al. used an unusually short TE of just 40ms.
We, and other similarly focused groups, understand the
limitations of this novel modality and hope that the article does
not discourage the application of BOLD-MRI to CKD assessment.
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Limitations of BOLD-MRI for
assessment of hypoxia in
chronically diseased human kidneys
To the Editor: The article by Michaely et al.1 describes a
sizeable population of patients with chronic kidney disease
(CKD) with different degrees of severity of renal failure, in
which blood oxygen level–dependent magnetic resonance
imaging (BOLD-MRI) was used as a non-invasive technique
for monitoring the degree of renal oxygenation. This study
addressed the contention that intrarenal chronic hypoxia
underlies the progressive nature of most forms of CKD.2–4
The authors were unable to discriminate between patients
with different stages of CKD using this method.
We would argue that BOLD-MRI is not the appropriate
method for assessing oxygenation in CKD given the speciﬁc
evolution of the pathology in this setting. BOLD-MRI measures
vascular oxygen saturation with the signal being indirectly
related to deoxyhemoglobin concentration.5,6 To compare
different stages of disease for the degree of hypoxia, the volume
of the vessels and the number of red blood cells must be the
same in the voxels being compared, to make the comparison
valid. The patchy involvement of the chronically diseased
kidney, in which microvascular obliteration occurs in the
tubule-interstitial compartment, means that the expression of
a single datum point to reﬂect the entire cortex or medulla
(as portrayed in the paper by Michaely et al.) would fail to
capture this heterogeneity in the early and mid-stages of the
disease. Expressing the variability of the BOLD signal intensity
or R2* of pixels contained within the measured region of interest
for each patient may be a more appropriate way to detect
differences.
Equally important, in more advanced disease, both micro-
vasculature loss and a diminished red blood cell mass occur as
CKD progresses. Hence, the source of the signal for deoxyhe-
moglobin concentration in a volume being measured would
be diluted as the disease progresses, thereby obscuring
functionally relevant local hypoxic regions and making com-
parisons with less advanced disease invalid.
We concur with the author of the accompanying editorial
that ‘limitations in the technique and execution’ lead to the
conclusion that ‘the hypoxia hypothesis has not been refuted’.7
The study is important, however, for raising the need for
more reﬁned use of BOLD-MRI or for alternative methods for
determining intrarenal hypoxia in CKD.
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The Author Replies: In their letters to the editor, two groups,
from Los Angeles1 and Saitama, Japan,2 respectively, raised
some concerns regarding the methodology and the results of
our previously published study on renal blood oxygen level–
dependent magnetic resonance imaging (BOLD-MRI) in a
non-selected patient group. The current literature on renal
BOLD-MRI and its applications presents heterogeneous
results regarding the correlation between R2* and the
estimated glomerular ﬁltration rate.3,4 These different
results are most likely due to a lack of understanding of the
complex interaction between the different types of renal
diseases, their speciﬁc pathophysiology, and the complex
magnetic resonance (MR) signal generation. The choice of
shorter echo times in our study is surely not a relevant factor
explaining the differences between our ﬁndings and the
ﬁndings of other research groups. In contrast, the use of 3T
MR mandates the use of shorter echo times to yield reliable
image quality even with the longest echo time used.5 In
addition, similar echo times as in our study have also been
used by the group of Prasad et al., who pioneered the ﬁeld of
renal BOLD-MRI. Much more interesting than these
technical details are the implications of our study that have
been addressed by the authors of these letters. We concur that
our study does not imply that BOLD-MRI of the kidneys
should not be done. The main conclusion of our study was
that ‘broad application of renal BOLD MRI seems not
suitable’.3 The use of BOLD imaging in dedicated patient
groups should not be discouraged. In contrast, further studies
in patient groups with similar pathophysiological changes or
intraindividual studies are warranted. Under these premises
the inﬂuence of altered microvascular density or of the red
blood cell count and altered medications could be better
controlled. Novel approaches for image analysis of the
parametric R2* maps, such as the suggested region-
of-interest–based histogram plot, might further provide better
insights into pathology.
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Drug use and nephrotoxicity in
the intensive care unit: are we
under-dosing antimicrobials in
patients with acute kidney injury
with the need of extended
dialysis?
To the Editor: An important aspect that we would like to
raise, in addition to what Dr Perazella described as drug dose
adjustment1 in a recent review in this journal, is the use of
antibiotics in extended dialysis (ED). With ED, patients with
acute kidney injury have a potentially supraphysiologic drug
clearance during ED procedures, and this may be detrimental
in patients for whom bactericidal concentrations of antibiotics
are needed. Therefore, when the antibiotic is given in relation to
ED may be as important as the dosing. This premise has been
demonstrated by Lorenzen et al.,2 who reported that ampicillin/
sulbactam given too early or late in relation to ED could result
in supra- or subtherapeutic concentrations. Also considered
should be the pharmacodynamic properties of the antimicrobial
in question. Antimicrobials require speciﬁc attention to their
pharmacodynamic activity, as drugs that are time-dependent
killers may require a different timing and dosing compared
with those that kill in a concentration-dependent manner.3
Taking these considerations into account may be difﬁcult
enough, but complexity is added by the intensive care unit
(ICU) environment, to which access is limited, and procedures
may interfere with drug and dialysis scheduling.
In addition, there is paucity in dosing information of several
antibiotics commonly used in the ICU in patients with ED. ED
pharmacokinetics has been conducted in very few drugs.4
We agree with Dr Perazella that dosing of medications in
critically ill patients with acute renal replacement therapy is
challenging, and that practitioners should seek best evidence
and adjust their recommendation of dialysis parameters and
timing to optimize the dosing of antimicrobials.
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